Literature DB >> 12580975

L-arginine levels are diminished in adult acute vaso-occlusive sickle cell crisis in the emergency department.

Bernard L Lopez1, Allyson A Kreshak, Claudia R Morris, Linda Davis-Moon, Samir K Ballas, Xin-Liang Ma.   

Abstract

Paediatric studies have demonstrated that l-arginine (l-arg), the precursor to nitric oxide, is diminished in vaso-occlusive crisis (VOC). This study aimed to determine whether l-arginine levels are altered in adult VOC in the emergency department. Plasma l-arg and nitric oxide metabolite (NOx) levels were obtained in adult VOC patients presenting to the emergency department. Fifty patients had significantly low plasma l-arg (29.78 micromol/l +/- 11.21, P < 0.05 vs steady-state control = 41.16 micromol/l +/- 5.04) and significantly low plasma NOx (12.33 micromol/l +/- 10.28, P < 0.05 vs steady-state control = 25.2 +/- 2.6 micro mol/l). Neither l-arg nor NOx levels could predict VOC clinical course.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12580975     DOI: 10.1046/j.1365-2141.2003.04109.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  19 in total

1.  Cerebrovascular disease associated with sickle cell pulmonary hypertension.

Authors:  Gregory J Kato; Matthew Hsieh; Roberto Machado; James Taylor; Jane Little; John A Butman; Tanya Lehky; John Tisdale; Mark T Gladwin
Journal:  Am J Hematol       Date:  2006-07       Impact factor: 10.047

Review 2.  cGMP modulation therapeutics for sickle cell disease.

Authors:  Nicola Conran; Lidiane Torres
Journal:  Exp Biol Med (Maywood)       Date:  2019-01-28

3.  Impact of arginine therapy on mitochondrial function in children with sickle cell disease during vaso-occlusive pain.

Authors:  Claudia R Morris; Lou Ann S Brown; Michael Reynolds; Carlton D Dampier; Peter A Lane; Amanda Watt; Polly Kumari; Frank Harris; Shaminy Manoranjithan; Reshika D Mendis; Janet Figueroa; Sruti Shiva
Journal:  Blood       Date:  2020-09-17       Impact factor: 22.113

4.  Study of correlation of nitrite levels with malonaldehyde and the prognosis of patients with sickle cell disease on hydroxyurea, Ceará-Brazil.

Authors:  Romélia Pinheiro Gonçalves; Darcielle Bruna Dias Elias; Hemerson Iury Ferreira Magalhães; Jacqueline Holanda de Souza
Journal:  J Clin Lab Anal       Date:  2011       Impact factor: 2.352

5.  Vasculopathy in sickle cell disease: Biology, pathophysiology, genetics, translational medicine, and new research directions.

Authors:  Gregory J Kato; Robert P Hebbel; Martin H Steinberg; Mark T Gladwin
Journal:  Am J Hematol       Date:  2009-09       Impact factor: 10.047

Review 6.  Pharmacotherapy in sickle cell disease--state of the art and future prospects.

Authors:  Jane Hankins; Banu Aygun
Journal:  Br J Haematol       Date:  2009-02-17       Impact factor: 6.998

Review 7.  Beyond the definitions of the phenotypic complications of sickle cell disease: an update on management.

Authors:  Samir K Ballas; Muge R Kesen; Morton F Goldberg; Gerard A Lutty; Carlton Dampier; Ifeyinwa Osunkwo; Winfred C Wang; Carolyn Hoppe; Ward Hagar; Deepika S Darbari; Punam Malik
Journal:  ScientificWorldJournal       Date:  2012-08-01

8.  Relationships between systemic vascular resistance, blood rheology and nitric oxide in children with sickle cell anemia or sickle cell-hemoglobin C disease.

Authors:  Yann Lamarre; Marie-Dominique Hardy-Dessources; Marc Romana; Marie-Laure Lalanne-Mistrih; Xavier Waltz; Marie Petras; Lydia Doumdo; Anne Blanchet-Deverly; Jean Martino; Benoît Tressières; Frederic Maillard; Vanessa Tarer; Maryse Etienne-Julan; Philippe Connes
Journal:  Clin Hemorheol Microcirc       Date:  2014       Impact factor: 2.375

9.  A randomized, placebo-controlled trial of arginine therapy for the treatment of children with sickle cell disease hospitalized with vaso-occlusive pain episodes.

Authors:  Claudia R Morris; Frans A Kuypers; Lisa Lavrisha; Michael Ansari; Nancy Sweeters; Melinee Stewart; Ginny Gildengorin; Lynne Neumayr; Elliott P Vichinsky
Journal:  Haematologica       Date:  2013-05-03       Impact factor: 9.941

10.  Genetic variants of GCH1 associate with chronic and acute crisis pain in African Americans with sickle cell disease.

Authors:  Nilanjana Sadhu; Ellie H Jhun; Yingwei Yao; Ying He; Robert E Molokie; Diana J Wilkie; Zaijie Jim Wang
Journal:  Exp Hematol       Date:  2018-07-19       Impact factor: 3.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.